5th International Conference on
Innovations and Advances in Cancer Research and Treatment
September 23–24, 2027 | Las Vegas, USA
30+ Years of Management Experience
Las Vegas, USA
Phone: +44 2045874848
WhatsApp: +44 7429481517, +91-9063818855

Cancer 2027

Home › Scientific Sessions › Cancer Biomarkers & Companion Diagnostics
Cancer Biomarkers & Companion Diagnostics

Cancer Biomarkers & Companion Diagnostics emphasizes the discovery, validation, and clinical application of biomarkers that support early detection, prognosis, treatment selection, and therapeutic monitoring. Companion diagnostics play a vital role in precision oncology by identifying patients most likely to benefit from targeted therapies and immunotherapies. This session welcomes research on molecular biomarkers, genomic profiling, predictive and prognostic markers, biomarker-driven clinical decision-making, and emerging diagnostic technologies that advance personalized cancer treatment.

  • Predictive Biomarkers
  • Companion Diagnostics
  • Molecular Profiling
  • Precision Oncology
  • Prognostic Biomarkers
  • Personalized Cancer Therapy

Related Sessions